AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,746 Cr | ₹4,817 Cr | ₹4,466 Cr | ₹4,012 Cr | ₹3,503 Cr |
What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹5,746 Cr |
| Mar2024 | ₹4,817 Cr |
| Mar2023 | ₹4,466 Cr |
| Mar2022 | ₹4,012 Cr |
| Mar2021 | ₹3,503 Cr |
How is Sundry Debtors of AUROBINDO PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,746 Cr | 19.29 | |
| Mar2024 | ₹4,817 Cr | 7.84 | |
| Mar2023 | ₹4,466 Cr | 11.32 | |
| Mar2022 | ₹4,012 Cr | 14.53 | |
| Mar2021 | ₹3,503 Cr | - | |
Compare Sundry Debtors of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹70,131.6 Cr | -2.1% | 11.3% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,102.0 Cr | -0.7% | 4.3% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,299.0 Cr | -0.6% | -2.6% | 6.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,753.0 Cr | 0.4% | 4.7% | 19.8% | Stock Analytics | |
| CIPLA | ₹121,735.0 Cr | -1.3% | -4.8% | 2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,155.0 Cr | -1.1% | -3.7% | 2.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.1% |
11.3% |
-2.1% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses